Liver Tests & Diagnostic Procedures

Blood tests, often called liver function tests (LFTs), measure liver enzymes and proteins such as ALT, AST, ALP, GGT, bilirubin, albumin, and prothrombin time (PT/INR). Despite the name, most of these values reflect liver cell injury or protein production rather than a single measure of "function." They can suggest inflammation, impaired bile flow, or reduced protein synthesis, and are often the first tests ordered when liver disease is suspected or when monitoring a known condition. A complete blood count and coagulation studies may be added for a fuller picture.

Common types include:

• Liver Function Tests (LFT panel)
• Complete blood count (CBC Panel)
• Metabolic & MAFLD/MASH Tests
• Thyroid Testing

These specialized blood tests look for specific causes of liver disease rather than general injury. Viral hepatitis testing detects current or past infection with hepatitis A, B, or C. Autoimmune antibody tests, such as ANA or anti-smooth muscle antibody, support evaluation for autoimmune hepatitis or related conditions, usually alongside a liver biopsy for confirmation. Genetic and metabolic tests help identify inherited conditions such as hereditary hemochromatosis, Wilson disease, or alpha-1 antitrypsin deficiency, and are generally used when there is a specific clinical suspicion rather than as routine screening.

Common types include:

• Viral Hepatitis Testing
• Autoimmune Antibody Testing
• Genetic and Metabolic Testing

Imaging and non-invasive tests examine the liver's structure without surgery. Abdominal ultrasound is usually the first imaging test ordered, while CT and MRI provide more detailed views when needed. Elastography techniques, such as FibroScan (transient elastography) or MR elastography, estimate liver stiffness and fat content to help assess fibrosis (scarring) and steatosis (fat buildup), often reducing the need for a biopsy. These tests complement blood work but generally cannot confirm the exact cause of liver disease on their own.

Common types include:

• Ultrasound-Based Imaging
• Cross-Sectional Imaging
• Elastography & Fibrosis Testing
• Liver Fat Quantification
• Nuclear & Specialized Imaging

Invasive testing involves a procedure rather than a blood draw or scan, and it's generally reserved for situations where non-invasive tests are inconclusive or a precise diagnosis is needed. A liver biopsy remains the most definitive way to stage fibrosis and assess inflammation, though non-invasive alternatives are used more often today. Other invasive procedures, such as measuring hepatic venous pressure or performing an upper endoscopy to check for varices, are typically used in people with more advanced liver disease, such as cirrhosis.

Common types include:

• Liver Biopsy
• Portal Pressure Assessment
• Endoscopic Assessment

Urine and stool tests are used less often than blood tests but can add useful information in specific situations. A urinalysis may show bilirubin or other changes linked to liver or bile duct problems. Specialized urine tests, such as 24-hour urinary copper measurement, support evaluation of certain inherited conditions like Wilson disease. Stool tests can help assess bile flow or rule out other causes of digestive symptoms that may overlap with liver disease.

Common types include:

• Urinalysis
• Specialized Urine Testing
• Stool Testing

Medical scores are calculation tools, not standalone tests. They combine existing lab values and clinical information into a single number that helps estimate fibrosis risk, disease severity, or prognosis. For example, FIB-4 uses age, AST, ALT, and platelet count to estimate the likelihood of significant fibrosis, while MELD and Child-Pugh scores help gauge the severity of advanced liver disease. These scores support clinical decision-making but don't replace a full evaluation by a provider.

Common types include:

• Liver Severity & Cirrhosis Scores
• Fibrosis Scores
• MAFLD / MASH Scores
• Hepatic Encephalopathy Scores
• Alcohol Associated Liver Disease Scores
• Liver Cancer Risk Scores
• ICU / Acute Liver Failure Scores

Liver cancer surveillance is generally recommended for people at higher risk of hepatocellular carcinoma (HCC), such as those with cirrhosis or chronic hepatitis B or C, rather than the general population. Surveillance typically combines routine ultrasound with a blood-based tumor marker, alpha-fetoprotein (AFP), usually every six months. An elevated AFP or a suspicious finding on ultrasound doesn't confirm cancer by itself — it prompts further imaging, such as a contrast-enhanced CT or MRI, and sometimes a biopsy, to reach a diagnosis.

Common types include:

• Tumor Marker Blood Tests
• HCC Imaging Surveillance

These tests evaluate specific complications that can develop with advanced liver disease, such as cirrhosis, rather than diagnosing the underlying liver condition itself. Ascites, a buildup of fluid in the abdomen, is usually assessed with a physical exam and ultrasound; a diagnostic paracentesis — removing a small fluid sample with a needle — may follow to check the fluid for infection or other causes. Hepatic encephalopathy, a decline in brain function caused by the liver's reduced ability to clear toxins, is diagnosed mainly through clinical evaluation of mental status, sometimes supported by blood ammonia testing or psychometric testing. These evaluations are generally used in people with an existing liver condition, not as routine screening.

Common types include:

• Ascites Testing
• Hepatic Encephalopathy Evaluation

These tests help evaluate whether alcohol use, medications, or other substances may be contributing to liver injury. Alcohol biomarker tests can indicate recent or heavy drinking, while drug-induced liver injury evaluation looks at the pattern and timing of enzyme changes in relation to specific medications or supplements. Toxicology testing may be used when exposure to environmental or industrial substances is a concern. These tests are typically used when a specific exposure is suspected, not as routine liver screening.

Common types include:

• Alcohol Biomarker Testing
• Drug-Induced Liver Injury (DILI) Evaluation
• Toxicology and Environmental Testing